QQ客服 官方微博 反馈留言

	Aclarubicin and low dose arabinoside cytosine (Ara-C) in combination with granulocyte colony stimulating factor (GCSF) in treating acute myeloid leukemia (AML) patients with relapsed or refractory disease and myelodysplasia syndrome (MDS): A multi-center study of 112 chinese patients
	Li, JM; Shen, Y; Wu, DP; Liang, H; Jin, J; Chen, FY; Song, YP; Wang, LM; Qiu, XF; Hou, M
	2004
卷号	104
期号	11
会议录	BLOOD
语种	英语
URL标识	查看原文
ISSN号	0006-4971
内容类型	会议论文
URI标识	http://www.corc.org.cn/handle/1471x/5644103
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Li, JM,Shen, Y,Wu, DP,et al. Aclarubicin and low dose arabinoside cytosine (Ara-C) in combination with granulocyte colony stimulating factor (GCSF) in treating acute myeloid leukemia (AML) patients with relapsed or refractory disease and myelodysplasia syndrome (MDS): A multi-center study of 112 chinese patients[C]. 见:.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。